How do I find out if I qualify for a chronic myelomonocytic leukemia study in Tennessee?

Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.

Do I have to live in Tennessee to take part?

Not necessarily. These studies have a site in Tennessee, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.

Does it cost anything to join a chronic myelomonocytic leukemia trial?

Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.

Clinical trials · Tennessee

Chronic Myelomonocytic Leukemia clinical trials in Tennessee

We’re tracking 4 recruiting chronic myelomonocytic leukemia studies with a site in Tennessee — including Phase 1, Phase 2 and Phase 2/Phase 3 studies, each written for real people, not researchers.

Recruiting studies in Tennessee

NCT04093570Enrolling by invitationPhase 2
Extension study for people continuing ASTX727 from a prior trial
This study checks whether continuing ASTX727 for people who already benefited from it in an earlier Taiho study is safe and effective. It may be an option if you stayed on ASTX727 at the end of your parent study and your doctor felt it was helping you.
Nashville, TennesseeAges 18 years+
NCT04256317RecruitingPhase 2/Phase 3
Azacitidine pills with or without venetoclax for certain blood cancers
This study tests whether a pill form of azacitidine (ASTX030) helps people with myelodysplastic syndromes (MDS), CMML, or AML. Some groups may also receive venetoclax; the goal is better blood cancer control for people who aren’t good candidates for intensive chemotherapy.
Nashville, TennesseeAges 18 years+
NCT06950034RecruitingPhase 1
Testing STX-0712 for advanced CMML or AML
This early-phase study tests a new drug called STX-0712 for people with certain types of blood cancers (CMML or AML) that have not responded to standard treatments. The goal is to see if the drug is safe and can help shrink or control the cancer.
Nashville, TennesseeAges 18 years+
NCT06994676RecruitingPhase 1
Study of CBX-250 for advanced myeloid leukemias
This study tests an experimental drug, CBX-250, for people with certain advanced blood cancers (like AML) that have not responded to standard treatments or have returned. The drug works only for people who have a specific genetic marker (HLA-A*02:01). The goal is to see if it is safe and how well it works.
Nashville, TennesseeAges 12 years+

Chronic Myelomonocytic Leukemia trials by city in Tennessee

Nashville

Where these studies are running in Tennessee

Institutions with a site for the recruiting chronic myelomonocytic leukemia studies listed above.

Vanderbilt University Medical Center · 4 studies
Sarah Cannon Research Institute

What taking part in a chronic myelomonocytic leukemia study involves

A screening visit first

Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.

Care at a nearby site

Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.

You stay in control

Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.

The team decides eligibility

Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.

Chronic Myelomonocytic Leukemia trials in other states

Common questions

Are there chronic myelomonocytic leukemia clinical trials in Tennessee?: Yes. We're currently tracking 4 recruiting chronic myelomonocytic leukemia studies with a site in Tennessee, each rewritten in plain language so you can see what it's testing and who it's for.
How do I find out if I qualify for a chronic myelomonocytic leukemia study in Tennessee?: Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
Do I have to live in Tennessee to take part?: Not necessarily. These studies have a site in Tennessee, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
Does it cost anything to join a chronic myelomonocytic leukemia trial?: Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.

Not the right time?

New chronic myelomonocytic leukemia studies open in Tennessee regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.

Get told when a study that fits you opens

Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.